Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis
NCT00555581
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Systemic Sclerosis
Interventions
DRUG:
Imatinib Mesylate
Sponsor
Hospital for Special Surgery, New York
Collaborators
[object Object]